Fmoc-Lys(Dabcyl)-OH structure
|
Common Name | Fmoc-Lys(Dabcyl)-OH | ||
---|---|---|---|---|
CAS Number | 146998-27-8 | Molecular Weight | 619.70900 | |
Density | 1.26 | Boiling Point | N/A | |
Molecular Formula | C36H37N5O5 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | N/A |
Use of Fmoc-Lys(Dabcyl)-OHFmoc-Lys(Dabcyl)-OH is a lysine derivative[1]. |
Name | (2S)-6-[[4-[[4-(dimethylamino)phenyl]diazenyl]benzoyl]amino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid |
---|---|
Synonym | More Synonyms |
Description | Fmoc-Lys(Dabcyl)-OH is a lysine derivative[1]. |
---|---|
Related Catalog | |
In Vitro | Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances[1]. |
References |
Density | 1.26 |
---|---|
Molecular Formula | C36H37N5O5 |
Molecular Weight | 619.70900 |
Exact Mass | 619.27900 |
PSA | 136.18000 |
LogP | 7.65530 |
Appearance of Characters | Crystalline Powder | Red |
Storage condition | 2-8°C |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
Automated Synthesis of Fluorogenic Protease Substrates: Design of Probes for Alzheimers Disease-Associated Proteases. Wang, G.T., et al.
Bioorg. Med. Chem. Lett. 2 , 1665, (1992)
|
|
Q.M. Wang et al.
Antiviral Chem. Chemother. 8 , 303, (1997)
|
Fmoc-Lys(Dabcyl)-OH |
N|A-4-[4-(Dimethylamino)phenylazo)benzoyl]-N|A-Fmoc-L-lysine |
AmbotzFAA1498 |
N|A-Fmoc-N|A-Dabcyl-L-lysine |
Fmoc-Lys(Dadcyl)-OH |
Nepsilon-4-[4-(Dimethylamino)phenylazo)benzoyl]-Nalpha-Fmoc-L-lysine |
Nalpha-Fmoc-Nepsilon-Dabcyl-L-lysine |
N6-[4-[[4-(Dimethylamino)phenyl]azo]benzoyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-lysine |